Recombinant staphylokinase - SupergeneAlternative Names: Fortelyzin; Forteplase; Gene modified staphylokinase - Supergene; Recombinant nonimmunogenic staphylokinase - Supergene; Recombinant staphylokinase variant - Supergene
Latest Information Update: 04 Dec 2014
At a glance
- Originator Supergene
- Class Metalloendopeptidases; Plasminogen activator enzymes; Recombinant proteins; Thrombolytics
- Mechanism of Action Plasminogen activators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Myocardial infarction
Most Recent Events
- 01 Oct 2014 Phase-III clinical trials in Myocardial infarction in Russia (IV)